An updated approach to healthcare-associated meningitis

References

• Sipahi OR. Economics of antibiotic resistance. Expert Rev Anti Infect Ther 2008;6(4):523-39
   PubMed Web of Science ®Google Scholar
• Bardak-Ozcem S, Sipahi OR. Approach To Hospital-acquired and Methicillin-resistant Staphylococcus Aureus Meningitis. Mediter J Infect Microb Antimicrob 2012;1:13
   Google Scholar
• Arda B, Sipahi OR, Atalay S, Ulusoy S. Pooled analysis of 2,408 cases of acute adult purulent meningitis from Turkey. Med Princ Pract 2008;17(1):76-9
   PubMed Web of Science ®Google Scholar
• Nau R, Djukic M, Spreer A, Eiffert H. Bacterial meningitis: new therapeutic approaches. Expert Rev Anti Infect Ther 2013;11(10):1079-95
   PubMed Web of Science ®Google Scholar
• Laxmi S, Tunkel AR. Healthcare-associated bacterial meningitis. Curr Infect Dis Rep 2011;13(4):367-73
   PubMedGoogle Scholar
• CDC/NHSN surveillance definitions for specific types of infections. Available from: www.cdc.gov/nhsn/pdfs/pscmanual/17pscnosinfdef_current.pdf [Last accessed on 25 January 2014]
   Google Scholar
• Palabiyikoglu I, Tekeli E, Cokca F, et al. Nosocomial meningitis in a university hospital between 1993 and 2002. J Hosp Infect 2006;62(1):94-7
   PubMed Web of Science ®Google Scholar
• Sato K, Lin TY, Weintrub L, et al. Bacteriological efficacy of nafcillin and vancomycin alone or combined with rifampicin or amikacin in experimental meningitis due to methicillin-susceptible or –resistant Staphylococcus aureus. Jpn J Antibiot 1985;38(8):2155-62
   PubMedGoogle Scholar
• Durand ML, Calderwood SB, Weber DJ, et al. Acute bacterial meningitis in adults. A review of 493 episodes. N Engl J Med 1993;328:21-8
   PubMed Web of Science ®Google Scholar
• Beer R, Lackner P, Pfausler B, Schmutzhard E. Nosocomial ventriculitis and meningitis in neurocritical care patients. J Neurol 2008;255(11):1617-24
   PubMed Web of Science ®Google Scholar
• Weisfelt M, Van de Beek D, Spanjaard L, de Gans J. Nosocomial bacterial meningitis in adults. A prospective series of 50 cases. J Hosp Infect 2007;66(1):71-8
   PubMed Web of Science ®Google Scholar
• Sacar S, Turgut H, Toprak S, et al. A retrospective study of central nervous system shunt infections diagnosed in a university hospital during a 4-year period. BMC Infect Dis 2006;6:43
   PubMed Web of Science ®Google Scholar
• Forster DH, Daschner FD. Acinetobacter species as nosocomial pathogens. Eur J Clin Microbiol Infect Dis 1998;17:73-7
   PubMed Web of Science ®Google Scholar
• Van de Beek D, Drake JM, Tunkel AR. Nosocomial bacterial meningitis. N Engl J Med 2010;362:146-54
   PubMed Web of Science ®Google Scholar
• Bayramoglu G, Kaya S, Besli Y, et al. Molecular epidemiology and the clinical significance of Acinetobacter baumannii complex isolated from cerebrospinal fluid in neurosurgical intensive care unit patients. Infection 2012;40(2):163-72
   PubMed Web of Science ®Google Scholar
• Moon C, Kwak YG, Kim BN, et al. Implications of postneurosurgical meningitis caused by carbapenem-resistant Acinetobacter baumannii. J Infect Chemother 2013;19(5):916-19
   PubMed Web of Science ®Google Scholar
• Wang JH, Lin PC, Chou CH, et al. Intraventricular antimicrobial therapy in postneurosurgical gram-negative bacillary meningitis or ventriculitis: a hospital-based retrospective study. J Microbiol Immunol Infect 2012. [Epub ahead of print]
   Google Scholar
• Nagaveni S, Rajeshwari H, Oli AK, et al. Widespread Emergence of Multidrug Resistant Pseudomonas aeruginosa Isolated from CSF Samples. Indian J Microbiol 2011;51(1):2-7
   PubMed Web of Science ®Google Scholar
• Scheithauer S, Bürgel U, Ryang YM, et al. Prospective surveillance of drain associated meningitis/ventriculitis in a neurosurgery and neurological intensive care unit. J Neurol Neurosurg Psychiatry 2009;80(12):1381-5
   PubMed Web of Science ®Google Scholar
• Levin AS, Levy CE, Manrique AE, et al. Severe nosocomial infections with imipenem-resistant Acinetobacter baumannii treated with ampicillin/sulbactam. Int J Antimicrob Agents 2003;21(1):58-62
   PubMed Web of Science ®Google Scholar
• Tunkel AR, Scheld WM. Acute meningitis. In: Bennett JE, Dolin R, Mandell GL, editors. Principles and practice of infectious diseases. 7th edition. Churchill Livingstone, NY, USA; 2010; p. 1189-230
   Google Scholar
• Pintado V, Meseguer MA, Fortún J, et al. Clinical study of 44 cases of Staphylococcus aureus meningitis. Eur J Clin Microbiol Infect Dis 2002;21:864-8
   PubMed Web of Science ®Google Scholar
• Arda B, Yamazhan T, Sipahi OR, et al. Ulusoy S, meningitis due to methicillin-resistant Staphylococcus aureus (MRSA): review of 10 cases. Int J Antimicrob Agents 2005;25:414-18
   PubMed Web of Science ®Google Scholar
• Sipahi OR, Bardak S, Turhan T, et al. Linezolid in the treatment of methicillin-resistant staphylococcal post-neurosurgical meningitis: a series of 17 cases. Scand J Infect Dis 2011;43:757-64
   PubMed Web of Science ®Google Scholar
• Aguilar J, Urday-Cornejo V, Donabedian S, et al. Staphylococcus aureus meningitis: case series and literature review. Medicine (Baltimore) 2010;89(2):117-25
   PubMed Web of Science ®Google Scholar
• Chaudhuri P, Martinez-Martin P, Kennedy PG, et al. EFNS guideline on the management of community-acquired bacterial meningitis: report of an EFNS Task Force on acute bacterial meningitis in older children and adults. Eur J Neurol 2008;15(7):649-59
   PubMed Web of Science ®Google Scholar
• Subfebrile. Available from: www.merriam-webster.com/medical/subfebrile [Last accessed on 20 January 2014]
   Google Scholar
• Erdem I, Hakan T, Metin F, et al. Clinical features, laboratory data management and the risk factors that affect the mortality in patients with postoperative meningitis. Neurol India 2008;56(4):433-7
   PubMed Web of Science ®Google Scholar
• Huang WC, Lee CH, Liu JW. Clinical characteristics and risk factors for mortality in patients with meningitis caused by Staphylococcus aureus and vancomycin minimal inhibitory concentrations against these isolates. J Microbiol Immunol Infect 2010;43(6):470-7
   PubMedGoogle Scholar
• Tunkel AR, Hartman BR. Practice guidelines for the management of bacterial meningitis. IDSA guidelines. Clin Infect Dis 2004;39:1267-84
   PubMed Web of Science ®Google Scholar
• Greenlee JE, Carroll KC. Cerebrospinal fluid in central nervous system infections. In: Scheld WM, Whitley RJ, Marra CM, editors. Infections of the central nervous system. 3rd edition. Lippincott Williams and Wilkins; Philadelphia, PA, USA: 2004. p. 5-30
   Google Scholar
• van de Beek D, Brouwer MC, Thwaites GE, Tunkel AR. Advances in treatment of bacterial meningitis. Lancet 2012;380(9854):1693-702
   PubMed Web of Science ®Google Scholar
• Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis 2011;52(3):e18-55
   PubMed Web of Science ®Google Scholar
• The Sanford guide to antimicrobial therapy 2011, 41st edition; 2011; p. 79-84
   Google Scholar
• Sipahi OR, Arda B, Yurtseven T, et al. Vancomycin versus teicoplanin in the therapy of experimental methicillin-resistant Staphylococcus aureus (MRSA) meningitis. Int J Antimicrob Agents 2005;26:412-15
   PubMed Web of Science ®Google Scholar
• Calik S, Turhan T, Yurtseven T, et al. Vancomycin versus linezolid in the treatment of methicillin-resistant Staphylococcus aureus meningitis in an experimental rabbit model. Med Sci Monit 2012;18(11):SC5-8
   PubMed Web of Science ®Google Scholar
• Ntziora F, Falagas ME. Linezolid for the treatment of patients with central nervous system infection. Ann Pharmacother 2007;41(2):296-308
   PubMed Web of Science ®Google Scholar
• Sipahi OR, Bardak-Ozcem S, Turhan T, et al. Vancomycin versus Linezolid in the Treatment of Methicillin-Resistant Staphylococcus aureus Meningitis. Surg Infect (Larchmt) 2013;14:357-62
   PubMed Web of Science ®Google Scholar
• Gerber P, Stucki A, Acosta F, et al. Daptomycin is more efficacious than vancomycin against a methicillin-susceptible Staphylococcus aureus in experimental meningitis. J Antimicrob Chemother 2006;57:720-3
   PubMed Web of Science ®Google Scholar
• Bardak-Ozcem S, Turhan T, Sipahi OR, et al. Daptomycin versus vancomycin in treatment of Methicillin-Resistant Staphylococcus aureus Meningitis in an experimental rabbit model. Antimicrob Agents Chemother 2013;57(3):1556-8
   PubMed Web of Science ®Google Scholar
• Riser MS, Bland CM, Rudisill CN, Bookstaver PB. Cerebrospinal Fluid Penetration of High-Dose Daptomycin in Suspected Staphylococcus aureus Meningitis. Ann Pharmacother 2010;44:1832-4
   PubMed Web of Science ®Google Scholar
• Lee DH, Palermo B, Chowdhury M. Successful treatment of methicillin-resistant Staphylococcus aureus meningitis with daptomycin. Clin Infect Dis 2008;47(4):588-90
   PubMed Web of Science ®Google Scholar
• Kelesidis T, Humphries R, Ward K, et al. Combination therapy with daptomycin, linezolid, and rifampin as treatment option for MRSA meningitis and bacteremia. Diagn Microbiol Infect Dis 2011;71(3):286-90
   PubMed Web of Science ®Google Scholar
• Jaspan HB, Brothers AW, Campbell AJ, et al. Multidrug-resistant Enterococcus faecium meningitis in a toddler:characterization of the organism and successful treatment with intraventricular daptomycin and intravenous tigecycline. Pediatr Infect Dis J 2010;29(4):379-81
   PubMed Web of Science ®Google Scholar
• Le J, Bookstaver PB, Rudisill CN, et al. Treatment of meningitis caused by vancomycin-resistant Enterococcus faecium: high-dose and combination daptomycin therapy. Ann Pharmacother 2010;44(12):2001-6
   PubMed Web of Science ®Google Scholar
• Elvy J, Porter D, Brown E. Treatment of external ventricular drain-associated ventriculitis caused by Enterococcus faecalis with intraventricular daptomycin. J Antimicrob Chemother 2008;61(2):461-2
   PubMed Web of Science ®Google Scholar
• Kim BN, Peleg AY, Lodise TP, et al. Management of meningitis due to antibiotic-resistant Acinetobacter species. Lancet Infect Dis 2009;9:245-55
   PubMed Web of Science ®Google Scholar
• Stahl JP, Bru JP, Fredj G, et al. Penetration of sulbactam into the cerebrospinal fluid of patients with bacterial meningitis receiving ampicillin therapy. Rev Infect Dis 1986;8(Suppl 5):S612-16
   Google Scholar
• Kendirli T, Aydín HI, Hacíhamdioğlu D, et al. Meningitis with multidrugresistant Acinetobacter baumannii treated with ampicillin/sulbactam. J Hosp Infect 2004;56(4):328
   PubMed Web of Science ®Google Scholar
• Sipahi OR, Pullukçu H, Taşbakan M, et al. A case of Acinetobacter baumannii meningitis successfully treated with high dose ampicillin/sulbactam after failure with meropenem. Ankem Dergisi 2006;20:236-8
   Google Scholar
• Sayin Kutlu S, Saçar S, Süzer T, et al. Successful treatment of a patient with multidrug resistant Acinetobacter baumannii meningitis with high dose ampicillin-sulbactam. Mikrobiyol Bul 2008;42(2):353-8
   PubMed Web of Science ®Google Scholar
• Ziaka M, Markantonis SL, Fousteri M, et al. Combined intravenous and intraventricular administration of colistin methanesulfonate in critically ill patients with central nervous system infection. Antimicrob Agents Chemother 2013;57(4):1938-40
   PubMed Web of Science ®Google Scholar
• Jiménez-Mejías ME, Pichardo-Guerrero C, Marquez-Rivas FJ, et al. Cerebrospinal fluid penetration and pharmacokinetic/pharmacodynamic parameters of intravenously administered colistin in a case of multidrug-resistant Acinetobacter baumannii meningitis. Eur J Clin Microbiol Infect Dis 2002;21:212-14
   PubMed Web of Science ®Google Scholar
• Ho YH, Wang LS, Chao HJ, et al. Successful treatment of meningitis caused by multidrugresistant Acinetobacter baumannii with intravenous and intrathecal colistin. J Microbiol Immunol Infect 2007;40:537-40
   PubMedGoogle Scholar
• Falagas ME, Bliziotis IA, Tam VH. Intraventricular or intrathecal use of polymyxins in patients with Gram-negative meningitis: a systematic review of the available evidence. Int J Antimicrob Agents 2007;29:9-25
   Web of Science ®Google Scholar
• Pachón-Ibáñez ME, Docobo-Pérez F, López-Rojas R, et al. Efficacy of rifampin and its combinations with imipenem, sulbactam, and colistin in experimental models of infection caused by imipenem-resistant Acinetobacter baumannii. Antimicrob Agents Chemother 2010;54(3):1165-72
   PubMed Web of Science ®Google Scholar
• Karvanen M, Plachouras D, Friberg LE, et al. Colistin methanesulfonate and colistin pharmacokinetics in critically ill patients receiving continuous venovenous hemodiafiltration. Antimicrob Agents Chemother 2013;57(1):668-71
   PubMed Web of Science ®Google Scholar
• Wadi JA, Rub MA. Multidrug resistant Acinetobacter nosocomial meningitis treated successfully with parenteral tigecycline. Ann Saudi Med 2007;27(6):456-8
   PubMed Web of Science ®Google Scholar
• Sipahi OR, Bardak S, Ozgiray E, et al. Multidrug resistant (MDR) Acinetobacter baumannii meningitis treated with tigecycline. In: Third Eurasia Congress of Infectious Diseases. Baku, Azerbaijan; 2009
   Google Scholar
• Fang G, Weiss W. Comparative efficacy of GAR-936 (GAR), a novel glycylcycline, alone and in combinatiun wirh vancomycin against penicillin-resistant S.pneumoniae (PRPS) experimental memigitis in rabbits. In: Fortieth İnterscience Conference on Antimicrobial Agents and Chemoteraphy. Toronto, Canada; 2000
   Google Scholar
• Corpus KA, Weber KB, Zimmerman CR. Intrathecal amikacin for the treatment of pseudomonal meningitis. Ann Pharmacother 2004;38(6):992-5
   PubMed Web of Science ®Google Scholar
• Bray DA, Calcaterra TC. Pseudomonas meningitis complicating head and neck surgery. Laryngoscope 1976;86(9):1386-90
   PubMed Web of Science ®Google Scholar
• Schina M, Spyridi E, Daoudakis M, et al. Successful treatment of multidrug-resistant Pseudomonas aeruginosa meningitis with intravenous and intrathecal colistin. Int J Infect Dis 2006;10(2):178-9
   PubMed Web of Science ®Google Scholar
• Quinn AL, Parada JP, Belmares J, O'Keefe JP. Intrathecal colistin and sterilization of resistant Pseudomonas aeruginosa shunt infection. Ann Pharmacother 2005;39(5):949-52
   PubMed Web of Science ®Google Scholar
• Hooper DC, Strahilevits J. Quinolones. In: Bennett JE, Dolin R, Mandell GL, editors. Principles and practice of infectious diseases. 7th edition. Churchill Livingstone; NY, USA: 2010. p. 487-510
   Google Scholar
• Lipman J, Allworth A, Wallis SC. Cerebrospinal fluid penetration of high doses of intravenous ciprofloxacin in meningitis. Clin Infect Dis 2000;31(5):1131-3
   PubMed Web of Science ®Google Scholar
• Krcméry V Jr, Filka J, Uher J, et al. Ciprofloxacin in treatment of nosocomial meningitis in neonates and in infants: report of 12 cases and review. Diagn Microbiol Infect Dis 1999;35(1):75-80
   PubMed Web of Science ®Google Scholar
• Arda B, Zeka AN, Bardak-Ozcem S, et al. Two Cases of Escherichia coli meningitis developing after transrectal prostate biopsy. Mediter J Infect Microb Antimicrob 2012;1:3
   Google Scholar
• Tunkel AR, Drake JM. Cerebrospinal fluid shunt infections. In: Bennett JE, Dolin R, Mandell GL, editors. Principles and practice of infectious diseases. 7th edition. Churchill Livingstone; NY, USA: 2010. p. 1231-6
   Google Scholar
• Pintado V, Cabellos C, Moreno S, et al. Enterococcal meningitis: a clinical study of 39 cases and review of the literature. Medicine (Baltimore) 2003;82(5):346-64
   PubMed Web of Science ®Google Scholar
• Yahav D, Lador A, Paul M, Leibovici L. Efficacy and safety of tigecycline: a systematic review and meta-analysis. J Antimicrob Chemother 2011;66(9):1963-71
   PubMed Web of Science ®Google Scholar
• van de Beek D, de Gans J, Spanjaard L, et al. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med 2004;351(18):1849-59
   PubMed Web of Science ®Google Scholar
• McCracken GH Jr, Mize SG, Threlkeld N. Intraventricular gentamicin therapy in Gram-negative bacillary meningitis of infancy. Report of the Second Neonatal Meningitis Cooperative Study Group. Lancet 1980;315:787-91
   Google Scholar
• Brouwer MC, Tunkel AR, van de Beek D. Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis. Clin Microbiol Rev 2010;23(3):467-92
   PubMed Web of Science ®Google Scholar
• Wang KW, Chang WN, Huang CR, et al. Post-neurosurgical nosocomial bacterial meningitis in adults: microbiology, clinical features, and outcomes. J Clin Neurosci 2005;12(6):647-50
   PubMed Web of Science ®Google Scholar
• Reichert MC, Medeiros EA, Ferraz FA. Hospital-acquired meningitis in patients undergoing craniotomy: incidence, evolution, and risk factors. Am J Infect Control 2002;30(3):158-64
   PubMed Web of Science ®Google Scholar
• Kim HI, Kim SW, Park GY, et al. The causes and treatment outcomes of 91 patients with adult nosocomial meningitis. Korean J Intern Med 2012;27(2):171-9
   PubMed Web of Science ®Google Scholar
• De Bels D, Korinek AM, Bismuth R, et al. Empirical treatment of adult postsurgical nosocomial meningitis. Acta Neurochir (Wien) 2002;144(10):989-95
   PubMed Web of Science ®Google Scholar
• Dizbay M, Güzel-Tunçcan Ö, Arman D, et al. Factors associated with mortality in nosocomial central nervous system infections. ANKEM Derg 2011;25(1):6-11
   Google Scholar
• Fong IW, Ranalli P. Staphylococcus aureus meningitis. QJM 1985;53:289-99
   Google Scholar
• Schlesinger LS, Ross SC, Schaberg DR. Staphylococcus aureus meningitis: a broad-based epidemiologic study. Medicine (Baltimore) 1987;66:148-56
   PubMed Web of Science ®Google Scholar
• Jensen AG, Espersen F, Skinhoj P, et al. Staphylococcus aureus meningitis. A review bof 104 nationwide, consecutive cases. Arch Intern Med 1993;153:1902-8
   PubMedGoogle Scholar
• Kim JH, Van der Horst C, Mulrow CD, Corey GR. Staphylococcus aureus meningitis: review of 28 cases. Rev Infect Dis 1989;11:698-706
   PubMedGoogle Scholar
• Gordon JJ, Harter DH, Phair JP. Meningitis due to Staphylococcus aureus. Am J Med 1985;78:965-9
   PubMed Web of Science ®Google Scholar
• Falco V, Almirante B, Pahissa A, et al. Meningitis caused by Staphylococcus aureus. Analysis of 16 cases. Med Clin (Barc) 1990;94:208-11
   PubMed Web of Science ®Google Scholar
• Pintado V, Pazos R, Jiménez-Mejías ME, et al. Methicillin-resistant Staphylococcus aureus meningitis in adults: a multicenter study of 86 cases. Medicine (Baltimore) 2012;91(1):10-17
   PubMed Web of Science ®Google Scholar
• Seto C, Ikeda A, Ohkawa M. [A case report of urinary tract infection and meningitis caused by methicillin-resistant Staphylococcus aureus (MRSA) after transurethral resection of the prostate]. Nihon Hinyokika Gakkai Zasshi 1999;90(3):466-9
   PubMedGoogle Scholar
• Mellon G, Clec'h C, Picard B, et al. Postsurgical meningitis due to multiresistant Acinetobacter baumannii successfully treated with high doses of ampicillin/sulbactam combined with rifampicin and fosfomycin. J Infect Chemother 2012;18(6):958-60
   PubMed Web of Science ®Google Scholar
• Erdem H, Ulu-Kilic A, Kilic S, et al. Efficacy and tolerability of antibiotic combinations in neurobrucellosis: results of the Istanbul study. Antimicrob Agents Chemother 2012;56(3):1523-8
   PubMed Web of Science ®Google Scholar
• Mourvillier B, Tubach F, van de Beek D, et al. Induced hypothermia in severe bacterial meningitis: a randomized clinical trial. JAMA 2013;310:2174-83
   PubMed Web of Science ®Google Scholar